AKTX

7.1807.00%
VV

Vatnak Vat-Ho

Chief Business Officer

Mr. Vatnak Vat-Ho, MBA, is Chief Business Officer of Akari Therapeutics, Plc from October 2026. Mr. Vat-Ho serves as Chief Business Officer at Ryvu Therapeutics S.A. since April 2021 and serves as Member of Management Board since August 01, 2022. Mr. Vat-Ho spent the first few years of his professional career in a variety of investment banks and global equity healthcare funds, later moving to the pharma and biotech industry. His experience includes a tenure at Pfizer where he held several roles, concluding in the position of Senior Director/Team Lead, Strategy, Business Development & Alliances in the commercial development organization. Mr. Vat-Ho served as Vice President, Business Development at Affimed Inc. where he was responsible for leading partnering activities for both the preclinical and clinical pipeline, as well as serving as alliance manager for its collaborations. Mr. Vat-Ho received his AB degree in Biology from Harvard University and MBA from New York University’s Leonard N. Stern School of Business.

Positions